Evaluation of Somatostatin Receptor Expression in PET 68Ga-DOTATOC in Patients Followed for Metastatic Breast Cancer

Clinical trial NCT06611891 · RECRUITING

Trial details

NCT number: NCT06611891
Sponsor: University Hospital, Grenoble
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Breast Cancer Metastatic

Start date: 2025-01-06
Primary completion: 2025-10-01
Enrollment: 25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.